DD299428A5 - Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung - Google Patents

Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung Download PDF

Info

Publication number
DD299428A5
DD299428A5 DD90343354A DD34335490A DD299428A5 DD 299428 A5 DD299428 A5 DD 299428A5 DD 90343354 A DD90343354 A DD 90343354A DD 34335490 A DD34335490 A DD 34335490A DD 299428 A5 DD299428 A5 DD 299428A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
oxo
methylene
meaning
spiro
Prior art date
Application number
DD90343354A
Other languages
German (de)
English (en)
Inventor
Edit Toth
Jozsef Toerley
Sandor Goeroeg
Laszlo Szporny
Bela Kiss
Eva Palosi
Dora Groo
Istvan Laszlovszky
Erzsebet Lapis
Ferenc Auth
Laszlo Gaal
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD299428A5 publication Critical patent/DD299428A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
DD90343354A 1989-08-10 1990-08-09 Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung DD299428A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894094A HU204276B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-4-methylen-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DD299428A5 true DD299428A5 (de) 1992-04-16

Family

ID=10966866

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90343354A DD299428A5 (de) 1989-08-10 1990-08-09 Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung
DD90343359A DD299431A5 (de) 1989-08-10 1990-08-09 Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90343359A DD299431A5 (de) 1989-08-10 1990-08-09 Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen

Country Status (26)

Country Link
US (2) US5132309A (sh)
EP (2) EP0412821B1 (sh)
JP (2) JPH0383985A (sh)
KR (2) KR940002826B1 (sh)
CN (1) CN1025031C (sh)
AT (2) ATE104671T1 (sh)
AU (2) AU621238B2 (sh)
CA (2) CA2023018C (sh)
DD (2) DD299428A5 (sh)
DE (2) DE69008275T2 (sh)
DK (1) DK0413516T3 (sh)
ES (2) ES2052179T3 (sh)
FI (1) FI93456C (sh)
HK (1) HK118295A (sh)
HU (2) HU204276B (sh)
IE (1) IE902885A1 (sh)
IL (2) IL95324A (sh)
IN (1) IN170979B (sh)
IS (1) IS3612A7 (sh)
MY (1) MY107240A (sh)
NO (1) NO903511L (sh)
NZ (2) NZ234843A (sh)
PL (2) PL163899B1 (sh)
SG (1) SG59864G (sh)
YU (2) YU150489A (sh)
ZA (3) ZA906300B (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752062T2 (de) * 1986-12-17 1997-09-11 Glaxo Group Ltd Verwendung von heterozyklischen Derivaten zur Herstellung von Arzneimitteln
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
GB9206989D0 (en) * 1992-03-31 1992-05-13 Glaxo Group Ltd Chemical compounds
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
US6100256A (en) * 1996-12-02 2000-08-08 Merck Sharp & Dohme Ltd. Use of NK-1 receptors antagonists for treating schizophrenic disorders
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
KR20030087248A (ko) * 2002-05-08 2003-11-14 (주)씨엔아이 온라인을 통한 상거래 기초항목의 설정기능을 갖는 상거래관리장치
US8921555B2 (en) * 2009-06-16 2014-12-30 Merck Sharp & Dohme Corp. Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416352D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (sh) * 1964-04-22
CH601304A5 (sh) * 1974-02-12 1978-07-14 Buskine Sa
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE104671T1 (de) 1994-05-15
MY107240A (en) 1995-10-31
AU6080390A (en) 1991-02-14
KR910004630A (ko) 1991-03-29
IL95325A (en) 1994-06-24
ES2052179T3 (es) 1994-07-01
CN1049349A (zh) 1991-02-20
ZA906304B (en) 1991-06-26
SG59864G (en) 1995-09-01
DE69008275D1 (de) 1994-05-26
EP0412821B1 (en) 1994-11-09
JPH0383985A (ja) 1991-04-09
HUT59375A (en) 1992-05-28
IE902885A1 (en) 1991-02-27
DD299431A5 (de) 1992-04-16
KR910004631A (ko) 1991-03-29
IL95324A0 (en) 1991-06-30
ES2063923T3 (es) 1995-01-16
ZA906300B (en) 1991-05-29
AU621238B2 (en) 1992-03-05
KR940002826B1 (ko) 1994-04-04
ATE113951T1 (de) 1994-11-15
CA2023018A1 (en) 1991-02-11
AU621771B2 (en) 1992-03-19
PL163899B1 (pl) 1994-05-31
DE69014008T2 (de) 1995-03-23
IN170979B (sh) 1992-06-27
US5132309A (en) 1992-07-21
ZA906299B (en) 1991-06-26
FI93456B (fi) 1994-12-30
HK118295A (en) 1995-07-28
HU206677B (en) 1992-12-28
JPH0381277A (ja) 1991-04-05
IL95325A0 (en) 1991-06-30
EP0413516A3 (en) 1991-11-27
DE69014008D1 (de) 1994-12-15
CA2023018C (en) 1995-11-28
NO903511L (no) 1991-02-11
HU204276B (en) 1991-12-30
NZ234843A (en) 1992-03-26
YU154090A (sh) 1992-12-21
NO903511D0 (no) 1990-08-09
PL286443A1 (en) 1992-01-13
FI903974A0 (fi) 1990-08-10
DK0413516T3 (da) 1994-05-24
YU150489A (sh) 1992-12-21
KR940000830B1 (ko) 1994-02-02
US5132303A (en) 1992-07-21
EP0412821A3 (en) 1991-11-27
IL95324A (en) 1994-02-27
EP0413516A2 (en) 1991-02-20
HUT55785A (en) 1991-06-28
DE69008275T2 (de) 1994-08-04
NZ234846A (en) 1992-03-26
CA2023015A1 (en) 1991-02-11
AU6080490A (en) 1991-02-14
CN1025031C (zh) 1994-06-15
PL291648A1 (en) 1992-06-01
EP0413516B1 (en) 1994-04-20
EP0412821A2 (en) 1991-02-13
HU903233D0 (en) 1990-10-28
FI93456C (fi) 1995-04-10
IS3612A7 (is) 1991-02-11
PL164662B1 (pl) 1994-09-30

Similar Documents

Publication Publication Date Title
DD299428A5 (de) Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung
AT392276B (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
EP0546388B1 (de) Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
DE3342164C2 (sh)
DE2451932A1 (de) 1-hydroxy-und 1-alkanoyloxy-3-alkyl-6, 6a,7,8,10,10a-hexahydro-9h-dibenzo eckige klammer auf b,d eckige klammer zu pyran-9one und verfahren zu ihrer herstellung
DD216716A5 (de) Verfahren zur herstellung von octahydrobenzo (f)chinolinen
EP0550895B1 (de) 4,13-Dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE10153737A1 (de) Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
DD299427A5 (de) Neue 1-oxa-2-oxo-8-aza-spiro(4,5)dekan-derivate und verfahren zu ihrer herstellung
DE60214138T2 (de) Isoxazolin-derivate als antidepressiva
DD299425A5 (de) Neue 4,4-disubstituierte piperidin-derivate und verfahren zu ihrer herstellung
DE3326724A1 (de) In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE2718455A1 (de) 1,3-dihydro-heteroarylspiro eckige klammer auf isobenzofuran eckige klammer zu e
EP0539803A1 (de) Triazaspirodecanon-Methyl-Chromane zur Bekämpfung von Erkrankungen des Zentralnervensystems
DE69918148T2 (de) Trizyclische delta3-pyridine als arzneimittel
EP0717043B1 (de) Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als selektive Kaliumkanalmodulatoren
CH620685A5 (sh)
DE2854727A1 (de) Polyfluorhydroxyisopropyl-substituierte bicyclische und tricyclische carbostyrile, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH634839A5 (de) Pyranochromonderivate und ihre verwendung in arzneimitteln zur behandlung von allergien.
DE60022341T2 (de) Tricyclische kondensierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE4019080A1 (de) Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE60204046T2 (de) N-heterocyclylhydrazide als neurotrophe mittel
DE2530005C3 (de) 6,11-Dihydrodibenzo [b,e] thiepin-Derivate und deren Salze, Verfahren zu ihrer Herstellung und diese Substanzen enthaltende pharmazeutische Zubereitungen
DE3520104A1 (de) Naphthoxazine, ihre herstellung und verwendung
DD299429A5 (de) Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee